Education
About Us
Working with TipRanks
Follow Us
Frank Torti Insider Profile
4 Followers
Frank Torti, Director at Sio Gene Therapies, holds ― shares in Sio Gene Therapies (Ticker: SIOX), holds ― shares in Myovant Sciences (Ticker: MYOV), holds ― shares in Urovant Sciences (Ticker: UROV). Most recently, Frank Torti ― shares of Sio Gene Therapies on ― for an estimated value of ―.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+304.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Frank Torti holds in companies
Most Profitable Insider Trade
The most profitable trade made by Frank Torti
Frank Torti's Trading History
Sio Gene Therapies
―
―
―
―
Myovant Sciences
―
―
―
―
Urovant Sciences
―
―
―
―
Arbutus Biopharma
―
Director
―
―
Immunovant
Apr 03, 2025
Director
Uninformative Buy
―
$22.61M
Roivant Sciences
Feb 23, 2026
President and Vant Chair
Uninformative Buy
11.55M
$405.50M
List of latest transactions for each holding click on a transaction to see Frank Torti's performance on stock
You May Also Like
Frank Torti insider profile FAQ
What is the percentage of profitable transactions made by Frank Torti?
The percentage of profitable transactions made by Frank Torti is 50%.
What is the average return per transaction made by Frank Torti?
The average return per transaction made by Frank Torti is 304.60%.
What stocks does Frank Torti hold?
Frank Torti holds: SIOX, MYOV, UROV, ABUS, IMVT, ROIV stocks.
What was Frank Torti’s latest transaction?
Frank Torti latest transaction was an Uninformative Buy of ―.
What was Frank Torti's most profitable transaction?
Frank Torti’s most profitable transaction was an Informative Buy of IMVT stock on September 29, 2022. The return on the trade was 613.50%.
What is Frank Torti's role in Sio Gene Therapies?
Frank Torti's role in Sio Gene Therapies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.